The move comes in the wake of a Parliamentary Standing Committee report asking the government to identify such drug makers who are changing or tweaking composition of essential medicines to flout the price control. The panel has also recommended that the department should take stringent action against such companies, in consultation with the heath ministry.
Companies often tweak composition of medicines or change their strength to dodge price control. Often, companies also opt to bring out their products from the purview of Drugs and Cosmetics Act by adding food related substitutes to the same.
However, the government fails to take action against such firm because of overlapping of powers and laws in between various ministries and departments such as Ministry of Health and Department of Pharma.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)